EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Non-coding RNAs-glycolysis axis in cancer therapy resistance: Insight into mechanism to therapeutic solution

Jiachen Tan, Qinzheng Xu, Nuruliarizki Shinta Pandupuspitasari, Faheem Ahmed Khan, Di Wu, Fei Sun, Chunjie Huang

Biochemical Pharmacology · 2025-12 · 242 · 117286

DOI: 10.1016/j.bcp.2025.117286 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Pharmacology, 2025-12. Verfasst von Jiachen Tan und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nantong University, Nantong 226001, China. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Neoplasms, RNA, Untranslated, Glycolysis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 153 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite advancements in cancer therapy, including radiotherapy and chemotherapy, resistance to cancer treatment remains a significant clinical challenge. Metabolic reprogramming and dysfunctional glycolysis, a defining characteristic of cancer cells, are commonly observed in drug-resistant cancer cells. Besides glycolytic enzymes, several signaling molecules-including EGFR, HIF-1α, AMPK, and β-catenin-are involved in the regulation of glycolysis and play crucial roles in mediating resistance to cancer therapy. Numerous studies have elucidated the pivotal role of non-coding RNAs (ncRNAs), particularly microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), in the modulation of cancer drug resistance. miRNAs dually regulate glycolysis-some inhibit glycolysis to overcome therapy resistance, while others promote glycolysis, inducing resistance in cancer cells. Recent investigations have underscored the critical function of competitive endogenous RNAs (ceRNAs) in modulating glycolytic pathways, indicating circRNA/lncRNA-miRNA-mRNA as an important regulatory network in cancer therapy resistance. Exosomal ncRNAs are another mediator of cancer therapy resistance; depending on the specific ncRNAs they carry, they can either promote or suppress glycolysis. In the final section, we demonstrated that herbal medicine can successfully mitigate drug resistance in cancer by modulating the ncRNA-glycolysis axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmNeoplasmsRNA, UntranslatedGlycolysisAntineoplastic AgentsHumansAnimalsRNA, Competitive EndogenousMicroRNAsMetabolic Reprogramming

Stichwörter der Autor:innen

Cancer therapy resistanceGlycolysisHerbal medicineNon-coding RNAsTumor microenvironment

Substanzen

RNA, UntranslatedAntineoplastic AgentsRNA, Competitive EndogenousMicroRNAs

Autor:innen und Institutionen

  • School of Medicine, Nantong University, Nantong 226001, China.
  • School of Medicine, Nantong University, Nantong 226001, China; Department of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Nantong 226001, China.
  • Animal Science Department, Faculty of Animal and Agricultural Sciences, Universitas Diponegoro, Semarang 50275, Indonesia; Food Sustainable Research Center (FORCE), Universitas Diponegoro, Semarang 50275, Indonesia.
  • Research Center for Animal Husbandry, National Research and Innovation Agency, Jakarta Pusat 10340, Indonesia; Stem Cell and Cancer Research, Semarang 50223, Indonesia.
  • School of Medicine, Nantong University, Nantong 226001, China. Electronic address: luckylife.wu@ntu.edu.cn.
  • School of Medicine, Nantong University, Nantong 226001, China; School of Basic Medical Sciences, Key Laboratory of Fertility Preservation and Maintenance of Ministry of Education, Ningxia Medical University, Yinchuan 75…

Förderung

  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Tan, J., Xu, Q., Pandupuspitasari, N. S., Khan, F. A., Wu, D., Sun, F., & Huang, C. (2025). Non-coding RNAs-glycolysis axis in cancer therapy resistance: Insight into mechanism to therapeutic solution. Biochemical Pharmacology, 242, 117286. https://doi.org/10.1016/j.bcp.2025.117286

Vancouver

Tan J, Xu Q, Pandupuspitasari NS, Khan FA, Wu D, Sun F, et al. Non-coding RNAs-glycolysis axis in cancer therapy resistance: Insight into mechanism to therapeutic solution. Biochemical Pharmacology. 2025;242:117286. doi:10.1016/j.bcp.2025.117286

BibTeX
@article{Tan2025,
  author = {Tan, Jiachen and Xu, Qinzheng and Pandupuspitasari, Nuruliarizki Shinta and Khan, Faheem Ahmed and Wu, Di and Sun, Fei and Huang, Chunjie},
  title = {Non-coding RNAs-glycolysis axis in cancer therapy resistance: Insight into mechanism to therapeutic solution},
  journal = {Biochemical Pharmacology},
  year = {2025},
  volume = {242},
  pages = {117286},
  doi = {10.1016/j.bcp.2025.117286}
}
Kostenlos starten →